New York Times CoNYT
Price$63.71Intrinsic value$71.0011% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $3B+15.2% YoYTTM through 30 Jun 2026
Net Income $392.8M+33.7% YoYTTM through 30 Jun 2026
Free Cash Flow $623MTTM through 30 Jun 2026

Margins

Current
Gross Margin49.0%
EBITDA Margin18.8%
Operating Margin12.7%
Net Margin13.2%

Returns

18.8%ROE
12.8%ROA
18.8%ROIC

Balance Sheet Health

Debt / Equity0.00x
Current Ratio1.35x
Net Debt-$1.1Bnet cash position
Cash & Equivalents$232.7M

Quality Metrics

Altman Z-Score9.68
Piotroski F-Score6 / 9
FCF Margin20.9%
Rule of 4025.4
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $2.8B
Diluted EPS$2.40TTM
'19'20'21'22'23'24'25
FY2025: $2.09

Dividend

$0.64Per share, FY20261.30%Yield+18.8%5-yr growth

Capital Allocation

R&D Spend$274.4M
Capex Intensity1.2%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.